SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 223 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,716,468 | -7.2% | 352,429 | +1.2% | 0.92% | -1.9% |
| Q2 2023 | $10,468,094 | -18.3% | 348,240 | -1.5% | 0.94% | -21.0% |
| Q1 2023 | $12,813,500 | +104868.5% | 353,671 | +3.3% | 1.19% | -2.3% |
| Q4 2022 | $12,207 | -99.9% | 342,226 | -3.6% | 1.22% | -3.5% |
| Q3 2022 | $12,018,000 | +15.3% | 355,024 | -1.5% | 1.26% | +21.7% |
| Q2 2022 | $10,425,000 | -4.2% | 360,483 | +7.0% | 1.04% | +20.3% |
| Q1 2022 | $10,887,000 | +16.4% | 336,846 | +5.0% | 0.86% | +21.8% |
| Q4 2021 | $9,353,000 | +3.0% | 320,742 | -5.8% | 0.71% | +0.6% |
| Q3 2021 | $9,084,000 | -2.0% | 340,617 | +13.1% | 0.70% | -0.1% |
| Q2 2021 | $9,272,000 | +12.3% | 301,139 | -4.5% | 0.70% | +9.0% |
| Q1 2021 | $8,253,000 | – | 315,241 | – | 0.64% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ASHFORD CAPITAL MANAGEMENT INC | 698,676 | $41,816,000 | 5.51% |
| Provident Investment Management, Inc. | 543,194 | $32,510,000 | 4.61% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 426,250 | $25,511,000 | 2.37% |
| KOPP INVESTMENT ADVISORS LLC | 41,879 | $2,506,000 | 2.35% |
| AlphaOne Investment Services, LLC | 126,279 | $7,558,000 | 2.17% |
| Ranger Investment Management | 468,933 | $28,066,000 | 1.96% |
| Bruce & Co., Inc. | 158,058 | $9,459,000 | 1.88% |
| Penserra Capital Management LLC | 244,371 | $29,030,000 | 1.83% |
| SHAKER INVESTMENTS LLC/OH | 49,642 | $2,971,000 | 1.83% |
| Bridge City Capital, LLC | 47,795 | $2,861,000 | 1.81% |